Cargando…

De Novo Development of Mitochondria-Targeted Molecular Probes Targeting Pink1

Mitochondria play central roles in maintaining cellular metabolic homeostasis, cell survival and cell death, and generate most of the cell’s energy. Mitochondria maintain their homeostasis by dynamic (fission and fusion) and quality control mechanisms, including mitophagy, the removal of damaged mit...

Descripción completa

Detalles Bibliográficos
Autores principales: Ben-Uliel, Shulamit Fluss, Zoabi, Faten Habrat, Slavin, Moriya, Sibony-Benyamini, Hadas, Kalisman, Nir, Qvit, Nir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9181014/
https://www.ncbi.nlm.nih.gov/pubmed/35682755
http://dx.doi.org/10.3390/ijms23116076
_version_ 1784723662882996224
author Ben-Uliel, Shulamit Fluss
Zoabi, Faten Habrat
Slavin, Moriya
Sibony-Benyamini, Hadas
Kalisman, Nir
Qvit, Nir
author_facet Ben-Uliel, Shulamit Fluss
Zoabi, Faten Habrat
Slavin, Moriya
Sibony-Benyamini, Hadas
Kalisman, Nir
Qvit, Nir
author_sort Ben-Uliel, Shulamit Fluss
collection PubMed
description Mitochondria play central roles in maintaining cellular metabolic homeostasis, cell survival and cell death, and generate most of the cell’s energy. Mitochondria maintain their homeostasis by dynamic (fission and fusion) and quality control mechanisms, including mitophagy, the removal of damaged mitochondria that is mediated mainly by the Pink1/Parkin pathway. Pink1 is a serine/threonine kinase which regulates mitochondrial function, hitherto many molecular mechanisms underlying Pink1 activity in mitochondrial homeostasis and cell fate remain unknown. Peptides are vital biological mediators that demonstrate remarkable potency, selectivity, and low toxicity, yet they have two major limitations, low oral bioavailability and poor stability. Herein, we rationally designed a linear peptide that targets Pink1 and, using straightforward chemistry, we developed molecular probes with drug-like properties to further characterize Pink1. Initially, we conjugated a cell-penetrating peptide and a cross-linker to map Pink1’s 3D structure and its interaction sites. Next, we conjugated a fluorescent dye for cell-imaging. Finally, we developed cyclic peptides with improved stability and binding affinity. Overall, we present a facile approach to converting a non-permeable linear peptide into a research tool possessing important properties for therapeutics. This is a general approach using straightforward chemistry that can be tailored for various applications by numerous laboratories.
format Online
Article
Text
id pubmed-9181014
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-91810142022-06-10 De Novo Development of Mitochondria-Targeted Molecular Probes Targeting Pink1 Ben-Uliel, Shulamit Fluss Zoabi, Faten Habrat Slavin, Moriya Sibony-Benyamini, Hadas Kalisman, Nir Qvit, Nir Int J Mol Sci Article Mitochondria play central roles in maintaining cellular metabolic homeostasis, cell survival and cell death, and generate most of the cell’s energy. Mitochondria maintain their homeostasis by dynamic (fission and fusion) and quality control mechanisms, including mitophagy, the removal of damaged mitochondria that is mediated mainly by the Pink1/Parkin pathway. Pink1 is a serine/threonine kinase which regulates mitochondrial function, hitherto many molecular mechanisms underlying Pink1 activity in mitochondrial homeostasis and cell fate remain unknown. Peptides are vital biological mediators that demonstrate remarkable potency, selectivity, and low toxicity, yet they have two major limitations, low oral bioavailability and poor stability. Herein, we rationally designed a linear peptide that targets Pink1 and, using straightforward chemistry, we developed molecular probes with drug-like properties to further characterize Pink1. Initially, we conjugated a cell-penetrating peptide and a cross-linker to map Pink1’s 3D structure and its interaction sites. Next, we conjugated a fluorescent dye for cell-imaging. Finally, we developed cyclic peptides with improved stability and binding affinity. Overall, we present a facile approach to converting a non-permeable linear peptide into a research tool possessing important properties for therapeutics. This is a general approach using straightforward chemistry that can be tailored for various applications by numerous laboratories. MDPI 2022-05-28 /pmc/articles/PMC9181014/ /pubmed/35682755 http://dx.doi.org/10.3390/ijms23116076 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Ben-Uliel, Shulamit Fluss
Zoabi, Faten Habrat
Slavin, Moriya
Sibony-Benyamini, Hadas
Kalisman, Nir
Qvit, Nir
De Novo Development of Mitochondria-Targeted Molecular Probes Targeting Pink1
title De Novo Development of Mitochondria-Targeted Molecular Probes Targeting Pink1
title_full De Novo Development of Mitochondria-Targeted Molecular Probes Targeting Pink1
title_fullStr De Novo Development of Mitochondria-Targeted Molecular Probes Targeting Pink1
title_full_unstemmed De Novo Development of Mitochondria-Targeted Molecular Probes Targeting Pink1
title_short De Novo Development of Mitochondria-Targeted Molecular Probes Targeting Pink1
title_sort de novo development of mitochondria-targeted molecular probes targeting pink1
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9181014/
https://www.ncbi.nlm.nih.gov/pubmed/35682755
http://dx.doi.org/10.3390/ijms23116076
work_keys_str_mv AT benulielshulamitfluss denovodevelopmentofmitochondriatargetedmolecularprobestargetingpink1
AT zoabifatenhabrat denovodevelopmentofmitochondriatargetedmolecularprobestargetingpink1
AT slavinmoriya denovodevelopmentofmitochondriatargetedmolecularprobestargetingpink1
AT sibonybenyaminihadas denovodevelopmentofmitochondriatargetedmolecularprobestargetingpink1
AT kalismannir denovodevelopmentofmitochondriatargetedmolecularprobestargetingpink1
AT qvitnir denovodevelopmentofmitochondriatargetedmolecularprobestargetingpink1